Charline Caumont

562 total citations
18 papers, 332 citations indexed

About

Charline Caumont is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Charline Caumont has authored 18 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Charline Caumont's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Neuroendocrine Tumor Research Advances (2 papers). Charline Caumont is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Neuroendocrine Tumor Research Advances (2 papers). Charline Caumont collaborates with scholars based in France, United States and Martinique. Charline Caumont's co-authors include Jean‐Philippe Merlio, Camille Buscail, Aurélie Bedel, Sandrine Dabernat, François Moreau‐Gaudry, Marion Marty, V. Vendrely, Isabelle Moranvillier, L. Chiche and Camille Laurent and has published in prestigious journals such as Scientific Reports, Journal of Investigative Dermatology and European Journal of Cancer.

In The Last Decade

Charline Caumont

16 papers receiving 330 citations

Peers

Charline Caumont
Fui Teen Chong Singapore
Julia Burkert United Kingdom
Sanaa Tahiri United States
Charline Caumont
Citations per year, relative to Charline Caumont Charline Caumont (= 1×) peers Liv B. Gansmo

Countries citing papers authored by Charline Caumont

Since Specialization
Citations

This map shows the geographic impact of Charline Caumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charline Caumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charline Caumont more than expected).

Fields of papers citing papers by Charline Caumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charline Caumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charline Caumont. The network helps show where Charline Caumont may publish in the future.

Co-authorship network of co-authors of Charline Caumont

This figure shows the co-authorship network connecting the top 25 collaborators of Charline Caumont. A scholar is included among the top collaborators of Charline Caumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charline Caumont. Charline Caumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Henrot, Pauline, et al.. (2025). COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors. Scientific Reports. 15(1). 17145–17145.
2.
Caumont, Charline, Isabelle Quintin‐Roué, Laurent Doucet, et al.. (2025). Fluorescent In Situ Hybridization Testing Allows the Diagnosis of NRG1 Gene Fusions in Lung and Pancreas Cancers with No Other Identified Oncogenic Driver. Cancers. 17(14). 2347–2347.
3.
Caumont, Charline, L. Dousset, M. Beylot‐Barry, et al.. (2023). Assessment of Liquid Biopsy in Primary Cutaneous Diffuse Large B-Cell Lymphoma–Leg Type. Journal of Investigative Dermatology. 143(7). 1326–1329.e5. 2 indexed citations
4.
Caumont, Charline, et al.. (2023). Performances of the Idylla GeneFusion Assay: contribution to a rapid diagnosis of targetable gene fusions in tumour samples. Journal of Clinical Pathology. 77(8). 561–567. 2 indexed citations
5.
Amintas, Samuel, Charline Caumont, Rémi Veillon, et al.. (2022). Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer. European Journal of Cancer. 172. 85–95. 24 indexed citations
6.
Rousseau, Benoı̂t, Julien Izotte, Jean‐William Dupuy, et al.. (2022). An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect. Neuro-Oncology Advances. 4(1). vdac018–vdac018. 8 indexed citations
7.
Caumont, Charline, Isabelle Quintin‐Roué, Elsa Magro, et al.. (2021). Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing. Pathology. 54(1). 55–62. 9 indexed citations
9.
Guy, Alexandre, et al.. (2021). Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(4). 755–764. 2 indexed citations
10.
Buscail, Étienne, Camille Buscail, Isabelle Moranvillier, et al.. (2019). CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma. Translational Oncology. 12(11). 1395–1403. 65 indexed citations
11.
Buscail, Étienne, Catherine Alix‐Panabières, Thomas Cauvin, et al.. (2019). High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery. Cancers. 11(11). 1656–1656. 103 indexed citations
12.
Caumont, Charline, Élodie Blanchard, Gaël Dournes, et al.. (2017). Assessment of BRAFV600E mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reaction. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(2). 247–258. 8 indexed citations
14.
Buscail, Étienne, Charline Caumont, Jean‐Philippe Merlio, et al.. (2017). In vitro comparative analysis of Circulating Tumour Cells detection in liquid biopsy for the diagnosis of pancreatic adenocarcinoma. Pancreatology. 17(3). S23–S23. 1 indexed citations
15.
Caumont, Charline, Rémi Veillon, Audrey Gros, et al.. (2015). Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma. Lung Cancer. 92. 15–18. 41 indexed citations
16.
Caumont, Charline, Caroline Dutriaux, David Cappellen, et al.. (2015). Primary digestive melanoma in association with tubular adenoma: a case report illustrating the distinction from metastatic colonic melanoma. Human Pathology. 48. 167–171. 4 indexed citations
17.
Perrier, Lionel, D. J. Heinz, Sandrine Baffert, et al.. (2015). Cost Of Genome Analysis: The Sanger Sequencing Method. Value in Health. 18(7). A353–A353. 3 indexed citations
18.
Désoubeaux, Guillaume, Charline Caumont, Christophe Passot, et al.. (2011). Two cases of opportunistic parasite infections in patients receiving alemtuzumab. Journal of Clinical Pathology. 65(1). 92–95. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026